SGLT2 Inhibitors: Unreal Primary Prevention? | Latest News RSS feed

SGLT2 Inhibitors: Unreal Primary Prevention? - Latest News

New Analysis Finds Hope for Reducing Heart Failure

The analysis discusses the strength of evidence that SGLT2 inhibitors have a class effect in preventing ... The potential for this class to become a tool in primary prevention is being closely watched ... read more

New diabetes drugs solidify their cardiovascular and renal benefits

CHICAGO – When the first results from a large trial that showed profound and unexpected benefits for preventing heart failure hospitalizations associated with use of the antihyperglycemic sodium-gluco... read more

Zynquista approval up in air following divided EMDAC vote

an assistant professor and director of clinical research at the Johns Hopkins Ciccarone Center for the Prevention of Heart Disease. But the real-world risk would be no different than that already seen ... read more

Looking for another news?

AstraZeneca's diabetes drug curbs heart failure, kidney risks

However, the medicine - belonging to a class of treatments known as SGLT2 inhibitors ... prevention. Because AstraZeneca's study also looked at patients without established CV disease, it potentially ... read more

AstraZeneca Group plc (AZN) CEO Pascal Soriot on Q2 2018 Results - Earnings Call Transcript

As we said the place where this is already been demonstrated with an SGLT2 inhibitor. With regard to the primary prevention actually the endpoint itself is all of the patients together, so it’ll be th... read more

Study reveals sotagliflozin in conjunction with insulin reduces average blood glucose levels

the ADA's peer-reviewed research journal dedicated to diabetes treatment and prevention. Sotagliflozin is an investigational dual inhibitor of sodium glucose transport proteins 1 and 2 (SGLT1 and SGLT... read more

Africa: How South Africa Can Beat Its Sugar-Fuelled Diabetes Epidemic

Non-governmental organisations receive little to no funding for diabetes education, prevention or supplies ... Other drugs from these classes (Incretins and SGLT2 inhibitors) help manage diabetes effe... read more

CHMP thumbs up for 11 new drugs

The drug, which was approved in the US in April, is a sodium-glucose co-transporter 2 (SGLT2) inhibitor that works by blocking the ... nasal spray vaccine Fluenz Tetra was recommended for the preventi... read more

Panel Meeting For Victoza And Decision Time For Portola's Anticoagulant

In its outcomes trial, Leader, Victoza's benefit was largely down to prevention of cardiovascular death ... Competition from the SGLT2 inhibitor class is likely to become even stiffer - Lilly and Boeh... read more

FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us